Genufood Energy Enzymes Corp.

OTC:GFOO

Medicinal Chemicals & Botanical Products·ARCADIA, CA

CEO

Lin Jui Pin

CFO

Wang Shao-Cheng

Summary Financials

Revenue

$60,993

FY 2013

Adj. EBITDA

-$347,959

-570.5% margin

FY 2023

Net Income

-$352,668

-578.2% margin

FY 2023

EPS (Diluted)

—

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$136,400

FY 2023

Total Debt

$100,746

FY 2022

Net Cash

$35,654

FY 2022

Enterprise Value

—

Debt / EBITDA

0.1x

FY 2013

EV / EBITDA

—

Employees

—

Revenue

$60,993

FY 2013

Adj. EBITDA

-$347,959

-570.5% margin

FY 2023

Net Income

-$352,668

-578.2% margin

FY 2023

EPS (Diluted)

—

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$136,400

FY 2023

Total Debt

$100,746

FY 2022

Net Cash

$35,654

FY 2022

Enterprise Value

—

Debt / EBITDA

0.1x

FY 2013

EV / EBITDA

—

Employees

—